SARS-CoV-2 infections in “less visible” hospital staff: The roles and safety of environmental services and allied health professionals

Gomez-Ochoa, 2021, COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes, Am J Epidemiol, 190, 161, 10.1093/aje/kwaa191 Lei, 2021, Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections, Allergy, 76, 551, 10.1111/all.14622 Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6 Duysburgh, 2021, Persistence of IgG response to SARS-CoV-2, Lancet Infect Dis, 21, 163, 10.1016/S1473-3099(20)30943-9 Byrne P, 2021, Immune response following infection with SARS-CoV-2 and other coronaviruses: a rapid review, Rev Med Virol, 31 Finkenzeller, 2020, [SARS-CoV-2 antibodies in ICU and clinic staff: from Germany's region with the highest infection rate], Med Klin Intensiv Notfmed, 115, S139, 10.1007/s00063-020-00761-5 Sotgiu, 2020, SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital, BMC Pulm Med, 20, 203, 10.1186/s12890-020-01237-0 Chu, 2020, Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis, Lancet, 395, 1973, 10.1016/S0140-6736(20)31142-9 Tabatabaeizadeh, 2021, Airborne transmission of COVID-19 and the role of face mask to prevent it: a systematic review and meta-analysis, Eur J Med Res, 26, 1, 10.1186/s40001-020-00475-6 Coto, 2020, The impact of COVID-19 on allied health professions, PLoS One, 15, 10.1371/journal.pone.0241328 Epstude, 2020, Seroprevalence of COVID-19 antibodies in the cleaning and oncological staff of a municipal clinic, GMS Hyg Infect Control, 15 Goenka, 2020, Seroprevalence of COVID-19 amongst health care workers in a tertiary care hospital of a metropolitan city from India, J Assoc Physicians India, 68, 14 Rosser, 2020, Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic, Infect Control Hosp Epidemiol, 1 Akinbami, 2020, SARS-CoV-2 seroprevalence among healthcare, first response, and public safety personnel, Detroit Metropolitan Area, Michigan, USA, May–June 2020, Emerg Infect Dis, 26, 2863, 10.3201/eid2612.203764 Sabetian, 2021, COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran, Virol J, 18, 58, 10.1186/s12985-021-01532-0 Hodgson, 2021, Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust, medRxiv WHO. Organisation: WHO/Countries/ Austria [Available from: 〈https://www.who.int/countries/aut/〉]. AGES. AGES dashboard COVID-19; 2021. WHO. Protocol for assessment of potential risk factors for 2019-novel coronavirus (COVID-19) infection among health care workers in a health care setting; 2019. Haslacher, 2018, Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank, Biopreserv Biobank, 16, 477, 10.1089/bio.2018.0032 Egger, 2020, Comparison of the Elecsys(R) anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma, Clin Chim Acta, 509, 18, 10.1016/j.cca.2020.05.049 Atzl, 2022, SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study, BMJ Open, 12, 10.1136/bmjopen-2021-052130 Austria S. 4,7 % der der österreichischen bevölkerung hatten Mitte/Ende Oktober Antikörper gegen SARS-CoV-2; 2020 [Available from: 〈http://www.statistik.at/web_de/presse/124959.html〉]. Austria S. COVID-19 Prävalenz November 2020- Ergebnisbericht Statistik.at: Statistik Austria; 2020 [Available from: 〈https://www.statistik.at/wcm/idc/idcplg?IdcService=GET_PDF_FILE&RevisionSelectionMethod=LatestReleased&dDocName=125521〉]. Hossain, 2021, Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: a systematic review and meta-analysis, EClinicalMedicine, 33, 10.1016/j.eclinm.2021.100770 Wiggen, 2022, SARS-CoV-2 seroprevalence among healthcare workers, PLoS One, 17, 10.1371/journal.pone.0266410 Bahrs, 2023, Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study, Infection, 1 Ahmad Malik, 2022, The impact of COVID-19 on comorbidities: a review of recent updates for combating it, Saudi J Biol Sci, 29, 3586, 10.1016/j.sjbs.2022.02.006 Malik, 2022, The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges, J Infect Public Health, 15, 228, 10.1016/j.jiph.2021.12.014 Farooqi, 2021, An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies, J Infect Public Health, 14, 1299, 10.1016/j.jiph.2021.08.014 Braun, 2021, Viral sequencing to investigate sources of SARS-CoV-2 infection in US healthcare personnel, Clin Infect Dis, 73, e1329, 10.1093/cid/ciab281